CIP
DXCM icon

Capital Insight Partners’s DexCom DXCM Stock Holding History

Capital Insight Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,834
Closed -$257K – 159
2024
Q3 		$257K Buy
3,834
+144
+4% +$11.8K 0.05% 143
2024
Q2 		$418K Buy
3,690
+90
+3% +$11.4K 0.08% 133
2024
Q1 		$499K Buy
3,600
+1,052
+41% +$132K 0.09% 135
2023
Q4 		$316K Buy
2,548
+252
+11% +$25.7K 0.06% 141
2023
Q3 		$214K Buy
2,296
+216
+10% +$24.3K 0.05% 158
2023
Q2 		$267K Buy
+2,080
New +$252K 0.06% 146

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital Insight Partners's DXCM Position: Q4 2024 in Review

Capital Insight Partners sold out of DexCom (DXCM) in Q4 2024, closing a stake of 3,834 shares — an estimated $257K sold.

Capital Insight Partners first reported a position in DXCM in Q2 2023 and held it in 6 quarters. The position peaked at $499K in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Capital Insight Partners reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Capital Insight Partners sold 3,834 DexCom shares in Q4 2024, an estimated $257K.
  • Capital Insight Partners first reported a position in DexCom in Q2 2023 and held it in 6 quarters.
  • Capital Insight Partners's DexCom position peaked at $499K in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Capital Insight Partners's 13F filing for Q4 2024, filed 24 Jan 2025.